Subcommittee on Health

Subcommittee on Health
Name	Subcommittee on Health
Chamber	House of Representatives
Parent committee	Committee on Energy and Commerce
Jurisdiction	Public health, biomedical research, medical products, mental health
Formed	20th century
Chair	TBD
Ranking member	TBD

Subcommittee on Health The Subcommittee on Health is a standing subcommittee within the United States House of Representatives tasked with matters relating to public health, biomedical research, medical product regulation, health workforce, and mental health policy. It interacts with federal agencies such as the United States Department of Health and Human Services, Centers for Disease Control and Prevention, Food and Drug Administration, and National Institutes of Health, and engages with stakeholders including academic institutions, professional associations, advocacy organizations, and industry groups. The subcommittee conducts hearings, drafts legislation, and exercises oversight over programs administered by departments and agencies influencing population health and medical innovation.

Overview

The subcommittee operates under the aegis of the Committee on Energy and Commerce and complements other panels such as the House Committee on Ways and Means and the House Committee on Education and Labor. Its work touches statutes including the Public Health Service Act, the Food, Drug, and Cosmetic Act, and provisions of the Affordable Care Act. It convenes witnesses from agencies like the National Institutes of Health, the Centers for Medicare & Medicaid Services, the Agency for Healthcare Research and Quality, and stakeholders such as the American Medical Association, the American Hospital Association, the Association of American Medical Colleges, and patient advocacy groups including American Cancer Society and Alzheimer's Association.

Jurisdiction and Responsibilities

Statutory and committee rules assign the subcommittee oversight of biomedical research funded by the National Institutes of Health, vaccine policy involving the Advisory Committee on Immunization Practices, regulation of drugs and biologics under the Food and Drug Administration, and blood and tissue safety policies implicating the American Red Cross and Centers for Disease Control and Prevention. It addresses workforce issues involving the Health Resources and Services Administration, behavioral health involving the Substance Abuse and Mental Health Services Administration, and public health emergencies coordinated with the Federal Emergency Management Agency and Office of the Assistant Secretary for Preparedness and Response. The subcommittee reviews programs like the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 and interacts with agencies such as the Office of Management and Budget during appropriations and oversight.

Membership and Leadership

Membership typically includes Representatives serving on the Committee on Energy and Commerce, including chairs and ranking members from both parties, and frequently features lawmakers with backgrounds linked to health policy such as those affiliated with the Congressional Black Caucus, the Congressional Hispanic Caucus, or the Problem Solvers Caucus. Past and present members have included notable legislators who advanced legislation alongside colleagues from the United States Senate and federal departments. Leadership roles coordinate with committee staff, counsels, and minority staff, and liaise with external offices such as the Office of the Speaker of the House and leadership offices like the Majority Leader of the United States House of Representatives.

Legislative Activities and Hearings

The subcommittee has held hearings that summoned agency officials from the Food and Drug Administration, the Centers for Disease Control and Prevention, and the National Institutes of Health alongside witnesses from academic centers such as Johns Hopkins University, Harvard Medical School, Mayo Clinic, and Massachusetts General Hospital. It has marked up bills related to drug pricing, opioid policy involving testimony from the Drug Enforcement Administration, vaccine access involving manufacturers like Pfizer and Moderna, and rare disease programs coordinated with the National Organization for Rare Disorders. Legislative actions have addressed issues intersecting with statutes like the 21st Century Cures Act and programs administered by the Centers for Medicare & Medicaid Services.

Oversight and Investigations

Oversight functions have included inquiries into pandemic preparedness involving the Centers for Disease Control and Prevention and the Biomedical Advanced Research and Development Authority, investigations into pharmaceutical manufacturing practices involving multinational companies and regulators, and reviews of clinical trial integrity in collaboration with institutions such as the Office of Inspector General of the Department of Health and Human Services and the Government Accountability Office. The subcommittee has issued subpoenas, held depositions, and published staff reports examining matters tied to supply chain resilience, vaccine distribution, diagnostic testing capacity at entities like Quest Diagnostics and LabCorp, and conflicts of interest involving academic-industry partnerships at universities.

Historical Development and Notable Actions

Since its establishment in the 20th century, the subcommittee played roles in shaping major health legislation and responses to public health crises including the response to HIV/AIDS in the late 20th century, the H1N1 influenza pandemic response, and policymaking during the COVID-19 pandemic. It contributed to enactments such as measures in the Orphan Drug Act era and to initiatives advancing biomedical innovation exemplified by the Bayh-Dole Act’s downstream effects on translational research. Notable actions include oversight of blood safety reforms following historic outbreaks, legislative responses to the opioid epidemic in coordination with the Department of Justice, and bipartisan efforts to reform vaccine confidence programs alongside public health institutions. The subcommittee’s hearings have featured testimony from medical researchers, public health leaders, patient advocates, industry executives, and legal scholars from institutions like Yale School of Medicine, Stanford Medicine, University of California, San Francisco, and Columbia University Irving Medical Center.

Category:United States House of Representatives subcommittees